Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01611727 | Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer Patients(Cisplatin) | completed | Phase 2 | 20 | Pomeranian Medical University SzczecinOTHER | 1 | Jul 12, 2012 | clinicaltrials |
| NCT00008437 | MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or Stage IIIA Breast Cancer | completed | Phase 2 | — | InSightecINDUSTRY | 2 | Jul 2, 2012 |
| clinicaltrials |
| NCT00464516 | Preoperative Estetrol in Breast Cancer | completed | Phase 2 | 30 | Pantarhei BioscienceINDUSTRY | 1 | Jul 2, 2012 | clinicaltrials |
| NCT00445406 | Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer | completed | Phase 2 | 43 | Swiss Cancer InstituteOTHER | 1 | Jun 28, 2012 | clinicaltrials |
| NCT00754351 | Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer | completed | Phase 2 | 48 | University Hospital of CreteOTHER | 1 | Jun 28, 2012 | clinicaltrials |
| NCT00076024 | AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 174 | PfizerINDUSTRY | 8 | Jun 26, 2012 | clinicaltrials |
| NCT00503750 | Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™) | completed | Phase 2 | 27 | Emory UniversityOTHER | 1 | Jun 25, 2012 | clinicaltrials |
| NCT01042938 | Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients | completed | Phase 2 | 35 | University of RochesterOTHER | 1 | Jun 25, 2012 | clinicaltrials |
| NCT00784849 | Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627) | completed | Phase 2 | 62 | Louisiana State University Health Sciences Center in New OrleansOTHER | 1 | Jun 20, 2012 | clinicaltrials |
| NCT00004172 | Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 12, 2012 | clinicaltrials |
| NCT00004175 | Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004182 | Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00006225 | Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00135018 | Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer | completed | Phase 2 | — | Organisation for Oncology and Translational ResearchOTHER | 1 | May 24, 2012 | clinicaltrials |
| NCT00048633 | Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advanced Breast Cancer | completed | Phase 2 | 30 | QLT Inc.INDUSTRY | 1 | May 23, 2012 | clinicaltrials |
| NCT00237627 | Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 107 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT00004046 | Chemotherapy in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | — | Daiichi SankyoINDUSTRY | 1 | May 16, 2012 | clinicaltrials |
| NCT00286819 | Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer | completed | Phase 2 | 50 | Central European Cooperative Oncology GroupOTHER | 4 | May 16, 2012 | clinicaltrials |
| NCT00003902 | Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement | completed | Phase 1 / Phase 2 | 110 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00031876 | Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 34 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00251472 | A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer | completed | Phase 2 | 72 | Veeda OncologyOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00768859 | Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study(TRAIN) | completed | Phase 2 | 111 | The Netherlands Cancer InstituteOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00083278 | Study of MDX-010 in Stage IV Breast Cancer | completed | Phase 2 | 33 | Bristol-Myers SquibbINDUSTRY | 1 | Apr 27, 2012 | clinicaltrials |
| NCT00467012 | Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer | completed | Phase 2 | 122 | Chugai PharmaceuticalINDUSTRY | 1 | Apr 26, 2012 | clinicaltrials |
| NCT00247663 | Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer | completed | Phase 2 | 17 | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 19, 2012 | clinicaltrials |
| NCT00816244 | Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer | completed | Phase 2 | 50 | Lund University HospitalOTHER | 1 | Apr 13, 2012 | clinicaltrials |
| NCT01208480 | Bevacizumab, Docetaxel, and Carboplatin in Treating Women With Stage II or Stage III Breast Cancer | completed | Phase 2 | 45 | Severance HospitalOTHER | 1 | Apr 10, 2012 | clinicaltrials |
| NCT00265655 | Satraplatin for Patients With Metastatic Breast Cancer (MBC) | completed | Phase 2 | 40 | AgennixINDUSTRY | 1 | Mar 28, 2012 | clinicaltrials |
| NCT01048528 | Health SMART (Stress Management and Relaxation Training) | completed | Phase 2 | 33 | Fred Hutchinson Cancer CenterOTHER | 1 | Mar 27, 2012 | clinicaltrials |
| NCT01089049 | Effect of a Natural Health Product on Urinary Estrogen Metabolites | completed | Phase 1 / Phase 2 | 98 | Nutrasource Pharmaceutical and Nutraceutical Services, Inc.NETWORK | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00019812 | Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2 | completed | Phase 2 | 55 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00149214 | Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens | completed | Phase 2 | 257 | Eli Lilly and CompanyINDUSTRY | 4 | Mar 21, 2012 | clinicaltrials |
| NCT00270894 | Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients | completed | Phase 2 | 30 | Accelerated Community Oncology Research NetworkOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00454532 | A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 27 | BionovoINDUSTRY | 0 | Mar 16, 2012 | clinicaltrials |
| NCT00002585 | Pyrazoloacridine in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 20 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00064311 | Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00301899 | Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab | completed | Phase 2 | 37 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00233974 | Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery | completed | Phase 2 | 15 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 7, 2012 | clinicaltrials |
| NCT00003392 | High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer | completed | Phase 2 | 61 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 22, 2012 | clinicaltrials |
| NCT00305448 | A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg(FINDER I) | completed | Phase 2 | 143 | AstraZenecaINDUSTRY | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00214864 | A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer | completed | Phase 2 | 18 | Cancer Research NetworkOTHER | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00006108 | Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | — | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01108315 | Comprehensive Patient Reported Outcomes (PRO) Management for Oncology Practice | completed | Phase 1 / Phase 2 | 138 | BrightOutcomeINDUSTRY | 1 | Feb 6, 2012 | clinicaltrials |
| NCT00243685 | Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis | completed | Phase 2 / Phase 3 | 150 | Pierian BiosciencesINDUSTRY | 1 | Jan 26, 2012 | clinicaltrials |
| NCT00206466 | Biologic Correlative Taxotere/AC(TAX/AC) | completed | Phase 2 | 70 | Baylor Breast Care CenterOTHER | 1 | Jan 25, 2012 | clinicaltrials |
| NCT00067314 | Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy | completed | Phase 2 | 65 | PfizerINDUSTRY | 4 | Jan 18, 2012 | clinicaltrials |
| NCT00623233 | Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer | completed | Phase 2 | 52 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 9, 2012 | clinicaltrials |
| NCT00448305 | EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients | completed | Phase 2 | 143 | MediGeneINDUSTRY | 6 | Jan 5, 2012 | clinicaltrials |
| NCT00532857 | Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab(PGH) | completed | Phase 2 | 53 | Jungsil RoOTHER_GOV | 1 | Jan 4, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jul 12, 2012source: clinicaltrials